ACUTE URINARY TOXICITY AFTER LOW-DOSE-RATE PERMANENT BRACHYTHERAPY FOR PROSTATE CANCER

被引：0
|
作者：
Takeda, K. [1 ]
Jingu, K. [1 ]
Koto, M. [1 ]
Fujimoto, K. [1 ]
Narazaki, K. [1 ]
Kubozono, M. [1 ]
Ariga, H. [1 ]
Saito, H. [2 ]
Yamada, S. [1 ,2 ]
Mitsudsuka, K. [2 ]
Ishidoya, S. [2 ]
Arai, Y. [2 ]
Yamada, S. [1 ,2 ]
机构：
[1] Tohoku Univ Hosp, Dept Radiat Oncol, Sendai, Miyagi, Japan
[2] Tohoku Univ Hosp, Dept Urol, Sendai, Miyagi, Japan
来源：
RADIOTHERAPY AND ONCOLOGY | 2010年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
547
引用
收藏
页码：S207 / S208
页数：2
相关论文
共 50 条
  • [31] The Incidence of Second Malignancies Following Low-Dose-Rate Brachytherapy for Prostate Cancer
    Hamilton, S.
    Tyldesley, S.
    Hamm, J.
    Keyes, M.
    Pickles, T.
    Lapointe, V.
    Kahnamelli, A.
    McKenzie, M.
    Miller, S.
    Morris, W. J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S424 - S425
  • [32] Role of androgen ablation with low-dose-rate brachytherapy in the treatment of prostate cancer
    Jani, Ashesh B.
    Shoushtari, Asal
    Feinstein, Jeffrey M.
    [J]. CLINICAL DRUG INVESTIGATION, 2006, 26 (12) : 723 - 731
  • [33] The impact of trainee involvement on outcomes in low-dose-rate brachytherapy for prostate cancer
    Shaikh, Talha
    Wang, Lora
    Ruth, Karen
    Hallman, Mark
    Chen, David Y.
    Greenberg, Richard E.
    Li, Jinsheng
    Crawford, Kevin
    Horwitz, Eric M.
    [J]. BRACHYTHERAPY, 2016, 15 (02) : 156 - 162
  • [34] The oncologic and safety outcomes of low-dose-rate brachytherapy for the treatment of prostate cancer
    Tanaka, Nobumichi
    [J]. PROSTATE INTERNATIONAL, 2023, 11 (03) : 127 - 133
  • [35] Control charts for evaluation of quality of low-dose-rate brachytherapy for prostate cancer
    Nasser, Nicola J.
    Saibishkumar, Elantholi P.
    Wang, Yinkun
    Chung, Peter W. M.
    Breen, Stephen L.
    [J]. JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2022, 14 (04) : 354 - 363
  • [36] Comparison of 4 EBRTs and low-dose-rate brachytherapy for localised prostate cancer
    Chang, K. H.
    Kim, D. W.
    Hong, C. S.
    Park, K. S.
    Byun, H. K.
    Kim, J.
    Han, M.
    Lee, H.
    Park, K.
    Kim, J. S.
    Cho, J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2019, 141 : S7 - S7
  • [37] Role of Androgen Ablation with Low-Dose-Rate Brachytherapy in the Treatment of Prostate Cancer
    Ashesh B. Jani
    Asal Shoushtari
    Jeffrey M. Feinstein
    [J]. Clinical Drug Investigation, 2006, 26 : 723 - 731
  • [38] Low-dose-rate or high-dose-rate brachytherapy in treatment of prostate cancer - between options
    Skowronek, Janusz
    [J]. JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2013, 5 (01) : 33 - 41
  • [39] Radiation protection and dosimetry issues for patients with prostate cancer after I-125 low-dose-rate brachytherapy permanent implant
    Licciardello, Tiziana
    Feliciani, Giacomo
    Mazzotti, Giorgio
    Mostacci, Domiziano
    Sarnelli, Anna
    Menghi, Enrico
    [J]. BRACHYTHERAPY, 2021, 20 (01) : 272 - 278
  • [40] Treatment patterns of high-dose-rate and low-dose-rate brachytherapy as monotherapy for prostate cancer
    Barnes, Justin
    Kennedy, William R.
    Fischer-Valuck, Benjamin W.
    Baumann, Brian C.
    Michalski, Jeff M.
    Gay, Hiram A.
    [J]. JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2019, 11 (04) : 320 - 328
12345